Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children
Clinical trial NCT01148459 · COMPLETED
Trial details
- NCT number
- NCT01148459
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-30
- Primary completion
- 2013-05-24
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.